Discontinued — last reported Q2 '25
McKesson International — Total revenues increased by 8.0% to $3.74B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $3.69B to $3.74B. Over 3 years (FY 2022 to FY 2025), International — Total revenues shows a downward trend with a -26.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in this metric indicates successful market expansion or increased demand for pharmaceutical distribution services abroad.
This metric represents the total gross sales generated by the international business segment from the distribution of ph...
Standard metric across all global wholesalers, comparable to 'International Segment Revenue' at peer firms like Cencora.
mck_segment_international_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.25B | $9.11B | $9.46B | $8.53B | $6.55B | $6.24B | $4.45B | $3.36B | $3.47B | $3.48B | $3.64B | $3.55B | $3.69B | $3.71B | $3.86B | $3.46B | $3.74B |
| QoQ Change | — | -1.5% | +3.9% | -9.8% | -23.2% | -4.8% | -28.7% | -24.4% | +3.1% | +0.2% | +4.7% | -2.5% | +4.0% | +0.5% | +4.1% | -10.3% | +8.0% |
| YoY Change | — | — | — | — | -29.2% | -31.5% | -53.0% | -60.6% | -47.0% | -44.3% | -18.2% | +5.5% | +6.4% | +6.7% | +6.1% | -2.5% | +1.3% |